We are looking for a keen surgically minded junior fellows at Southampton. Ideal for those looking to do an F3 year. 4 months rotations across various surgical specialities. Please apply if you are interested!
https://t.co/ScqxllHmJz
Join us for the National HPB Research Meeting: Shaping the Future of HPB Research
🗓 Friday, 27 June 2025
📍 Royal College of Surgeons of England
💡 Trial design, NIHR applications, big data, breakout rooms, CI/PI roles & more
🔗 Register now: https://t.co/cythN8OaQa
New RCT: Antibiotics vs appendectomy for uncomplicated appendicitis in children
❌Failure: 34% antibiotics vs 7% appendectomy
❌With 20% (!!) non-inferiority margin 👉 Antibiotics inferior
❌4 times more mild-moderate adverse events in antibiotic group
https://t.co/OmdvviYhRS
Latest findings from the @covidharem dataset on non-operative management of appendicitis have been published!
At 1 year, 71% of patients hadn't had an appendicectomy.
Presence of a faecolith and high AAS were key predictors of recurrence.
Read more: https://t.co/0xDAqKMMZS
📢Join us for the next #HPBCases session on Pancreatic NET.
Don't miss this insightful discussion!
📅Date: 26th September 2024 - 1900 CET
Register: https://t.co/CqaDy1lewt
@IhPBA@AHPBA@APHPBA
@ASCO#ASCO24#ESOsm
🥇ESOPEC #plenary
FLOT v CROSS loc adv EAC
📌 N=438, 80%cN+
➡️OS 58% FLOT V 50%, CROSS HR 0.7
pCR 17% v10%
🤔 CROSS underperformed…
How does adjuvant nivo post CROSS impact?
@OncoAlert
🔬 Calling All Oesophageal Cancer MDT Members! - please give us your views on AI-based decision-support tools for MDT decisions, and which factors matter most to you.🩺
📝 Please spare 10 minutes for our survey:
https://t.co/qVBhRlTR24
Thanks! 🌟
@BritSocGastro@AUGIShealth
VESTIGE: Adjuvant immunotherapy in pts with resected GEA following preoperative chemotherapy with high risk for recurrence presented by @LizzySmyth1 at #WCGIC2023
🔎EORTC phs II study
unfortunately⛔️
👉Adj. Nivo/IPI did not improve DFS & OS compared to CTx
@myESMO @WCGIC @OncoAlert